Free Cooler. Join for Life.

Nanoparticle Reduces Skin And Lung Scarring For Scleroderma, Mouse Study Finds

March 7, 2022

 • 

Read time:

<5 mins
Share on facebook
Share on twitter
Share on reddit
Share on email
Share on print
Lungs 1200
Share on facebook
Share on twitter
Share on reddit
Share on email
Share on print
Presented by Health Lab

A team of researchers from the Michigan Medicine Division of Rheumatology and Northwestern University Feinberg School of Medicine recently discovered that a biodegradable nanoparticle used in medical sutures could combat scleroderma, a rare and sometimes fatal autoimmune disease. John Varga, M.D., senior author of the paper and chief of the Michigan Medicine Division of Rheumatology, discusses the team’s findings, including the discovery of MARCO+, a unique macrophage that removes bacteria or dead cells, playing a key role in the chronic inflammation and scarring in the lungs and skin of people with scleroderma, or systemic sclerosis.

More from the Alumni Education Gateway
Join the Alumni Education Gateway Email List​
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.